MIGVAX
MigVax is an Israeli medical technology startup.
MIGVAX
Industry:
Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Misgav, HaZafon, Israel
Country:
Israel
Website Url:
http://www.migvax.com
Total Employee:
1+
Status:
Active
Contact:
+972-4-6953511
Email Addresses:
[email protected]
Total Funding:
16.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro COVID-19 Wix
Similar Organizations
Healthwire
Healthwire is a health-tech startup.
Current Employees Featured
Investors List
Coalition for Epidemic Preparedness Innovations
Coalition for Epidemic Preparedness Innovations investment in Grant - MigVax
OurCrowd
OurCrowd investment in Venture Round - MigVax
Official Site Inspections
http://www.migvax.com Semrush global rank: 7.92 M Semrush visits lastest month: 410
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "MigVax"
About | MigVax
Mission and Values MigVax was established in 2020 via a leading investment from OurCrowd, the crowdfunding venture investment platform, MigVax set out to modify a well-established …See details»
MigVax - Crunchbase Company Profile & Funding
MigVax is an Israeli medical technology startup.Headquarters Regions Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa …See details»
MigVax 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for MigVax. Use the PitchBook Platform to explore the full profile.See details»
MigVax - Israeli Startup | Startup Nation Finder
Nov 5, 2021 MigVax Overview MigVax was established as a special purpose vehicle by Migal, which granted MigVax an exclusive, worldwide license to make, use, and practice the vaccine technology for the development, manufacture, …See details»
MigVax Company Profile | Management and Employees List
MigVax Profile and History MigVax Ltd. is a biotechnology company focused on developing an oral subunit vaccine for COVID-19, designed to generate comprehensive immune responses …See details»
MigVax - LinkedIn
MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated personsSee details»
MigVax Company Profile - Office Locations, Competitors, Revenue …
MigVax $12 m in total funding,. See insights on MigVax including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
CEPI announces first funding awards in quest to develop ‘variant …
Nov 4, 2021 CEPI's partnerships with MigVax Ltd and the University of Saskatchewan's Vaccine and Infectious Disease Organization are kicking off our ambitious programme to develop …See details»
Covid-19 Vaccine Development by Migvax, MIGAL SPV
MigVax, a SPV by MIGAL is developing a vaccine for COVID-19, Coronavirus in human.See details»
Management | MigVax
Prof. Itamar Shalit SAB Clinical Prof Itamar Shalit is an expert in infectious diseases, actively involved in various national committees of the Israeli Ministry of Health. He was awarded …See details»
News | MigVax
May 31, 2022 Catalent and MigVax Sign Agreement to Develop an Orally Disintegrating Freeze-Dried Tablet Vaccine Against COVID-19 June 7th, 2022 MigVax Appoints Ran Amir As Its …See details»
MigVax-101 - Wikipedia
MigVax-101 is a COVID-19 vaccine candidate developed by Oravax Medical. [1][2][3]See details»
MigVax - 2025 Company Profile, Funding & Competitors - Tracxn
Apr 28, 2025 MigVax is a series B company based in Nazareth (Israel), founded in 1979. It operates as a Developer of vaccines for coronavirus treatment. MigVax has raised $12M in …See details»
Invest in MigVax private stocks | OurCrowd.com
MigVax’s innovation is based upon research at the Migal Galilee Research Institute, its parent organization, into an oral vaccine for a deadly avian (poultry) coronavirus whose infection …See details»
Israeli vaccine developer gets millions to develop variant-proof ...
Nov 10, 2021 The Coalition for Epidemic Preparedness Innovations (CEPI) is granting $4.3 million to Israel’s MigVax to advance development of Covid-19 vaccines suitable for use in low …See details»
MigVax - VentureRadar
MigVax is developing an oral COVID-19 sub-unit vaccine. The MigVax approach utilizes a chimeric protein that presents the viral proteins to the immune system via the oropharynx. This …See details»
MigVax - Company Information, Competitors, News & FAQs
Find useful insights on MigVax's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at MigVax.See details»
Israel’s MigVax oral vaccine scores $4.3m. to fast-track development
Nov 5, 2021 Israel’s MigVax has received a grant of $4.3 million to help develop its COVID-19 oral subunit vaccine tablet from the Coalition of Epidemic Preparedness Innovations (CEPI), …See details»
MigVax | VentureRadar
MigVax is developing an oral COVID-19 sub-unit vaccine. The MigVax approach utilizes a chimeric protein that presents the viral proteins to the immune system via the oropharynx. This …See details»
How a new global vaccine stockpile will help to counter the …
1 day ago A year after the World Health Organization (WHO) declared mpox a public health emergency of international concern (PHEIC), the virus has spread rapidly across Africa, and …See details»